Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
417 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02116959 | Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma | terminated | Phase 1 | 6 | University of California, San FranciscoOTHER | 1 | Apr 16, 2020 | clinicaltrials |
| NCT04079556 | Reducing Breast Cancer Risk in Korean American Women | completed | N/A | 48 | University of California, San FranciscoOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT03479385 | Integrative Approaches to Cancer Survivorship: Project 3(IACS2) | completed | N/A | 30 | University of California, San FranciscoOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT00539617 | Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery | terminated | Phase 2 | 7 | University of California, San FranciscoOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT01596699 | Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation | terminated | Phase 2 | 16 | University of California, San FranciscoOTHER | 1 | Feb 26, 2020 | clinicaltrials |
| NCT03174444 | Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans(SMILES) | completed | N/A | 1,707 | University of California, San FranciscoOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT01787331 | Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer | completed | Phase 2 | 21 | University of California, San FranciscoOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT02587650 | Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma | terminated | Phase 2 | 1 | University of California, San FranciscoOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT00467220 | Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer(1072) | completed | N/A | 24 | University of California, San FranciscoOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02783495 | Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients | terminated | N/A | 11 | University of California, San FranciscoOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT01557608 | Characterization and Treatment of Chemotherapy Neuropathy(CIN) | completed | N/A | 754 | University of California, San FranciscoOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT00616122 | Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | University of California, San FranciscoOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT03232892 | Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer | terminated | Phase 2 | 1 | University of California, San FranciscoOTHER | 1 | Dec 3, 2019 | clinicaltrials |
| NCT02918357 | Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence(PSMA BCR) | completed | Phase 2 / Phase 3 | 385 | University of California, San FranciscoOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT00488982 | Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC) | completed | Phase 2 | 125 | University of California, San FranciscoOTHER | 1 | Nov 20, 2019 | clinicaltrials |
| NCT02470741 | Pilot of Letrozole for Uterine Myomas(PLUM) | completed | Phase 4 | 12 | University of California, San FranciscoOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT02442635 | Yoga During Chemotherapy Study | completed | N/A | 73 | University of California, San FranciscoOTHER | 1 | Nov 14, 2019 | clinicaltrials |
| NCT02177773 | GA-68 DOTA-TOC of Somatostatin Positive Malignancies(DOTA-TOC) | terminated | Phase 1 / Phase 2 | 300 | University of California, San FranciscoOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT01377519 | Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids(PROMISe) | completed | N/A | 20 | University of California, San FranciscoOTHER | 1 | Nov 5, 2019 | clinicaltrials |
| NCT03311672 | T-Cell PET Imaging With [18F]F-AraG in Lung Cancer | withdrawn | Phase 2 | 0 | University of California, San FranciscoOTHER | 0 | Oct 21, 2019 | clinicaltrials |
| NCT03313193 | Acupressure for Children in Treatment for a Childhood Cancer(ACT-CC) | completed | N/A | 95 | University of California, San FranciscoOTHER | 1 | Oct 11, 2019 | clinicaltrials |
| NCT02776891 | A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma | withdrawn | Phase 2 | 0 | University of California, San FranciscoOTHER | 0 | Oct 10, 2019 | clinicaltrials |
| NCT02950480 | Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial | terminated | Phase 2 | 4 | University of California, San FranciscoOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT02270021 | Decreasing Over Screening and Treatment of Cervical Precancers in Young Women | completed | N/A | 42 | University of California, San FranciscoOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT02147301 | TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve | terminated | N/A | 17 | University of California, San FranciscoOTHER | 1 | Sep 10, 2019 | clinicaltrials |
| NCT02233595 | Evaluation of Rectal Cancer Treatment Response Using PET/MRI(Rectal PET/MRI) | terminated | — | 7 | University of California, San FranciscoOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT02613260 | Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System | completed | N/A | 13,470 | University of California, San FranciscoOTHER | 1 | Aug 9, 2019 | clinicaltrials |
| NCT00309894 | Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy | completed | Phase 2 | 49 | University of California, San FranciscoOTHER | 1 | Aug 5, 2019 | clinicaltrials |
| NCT01009307 | Study of Blood and Cheek Cell Samples From Patients With Glioma | completed | — | 1,709 | University of California, San FranciscoOTHER | 1 | Jul 22, 2019 | clinicaltrials |
| NCT01116661 | Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain(ALA) | terminated | Phase 2 | 199 | University of California, San FranciscoOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT01290523 | Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma | terminated | N/A | 14 | University of California, San FranciscoOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT01008917 | Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 1 | 25 | University of California, San FranciscoOTHER | 1 | May 9, 2019 | clinicaltrials |
| NCT01313936 | High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma | completed | Phase 1 | 32 | University of California, San FranciscoOTHER | 1 | Apr 29, 2019 | clinicaltrials |
| NCT01463046 | Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | completed | Phase 1 | 29 | University of California, San FranciscoOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT00924950 | Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis | terminated | Phase 4 | 35 | University of California, San FranciscoOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT02931552 | Nuevo Amanecer II: Translating a Stress Management Program for Latinas | completed | N/A | 153 | University of California, San FranciscoOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT02897544 | Integrative Approaches for Cancer Survivorship 2: Project 2(IACS2) | completed | N/A | 20 | University of California, San FranciscoOTHER | 1 | Mar 5, 2019 | clinicaltrials |
| NCT02897635 | Integrative Approaches For Cancer Survivorship 2: Project 1(IACS2) | completed | N/A | 20 | University of California, San FranciscoOTHER | 1 | Mar 5, 2019 | clinicaltrials |
| NCT02470936 | Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8(Prostate 8) | completed | N/A | 76 | University of California, San FranciscoOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT00313729 | Temozolomide in Treating Patients With Low-Grade Glioma | completed | Phase 2 | 120 | University of California, San FranciscoOTHER | 1 | Feb 7, 2019 | clinicaltrials |
| NCT01383174 | Nuevo Amanecer: Promoting the Psychosocial Health of Latinas | completed | N/A | 151 | University of California, San FranciscoOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03419130 | Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer | withdrawn | Phase 2 | 0 | University of California, San FranciscoOTHER | 1 | Dec 7, 2018 | clinicaltrials |
| NCT02450201 | MRI With C13 Pilot Study Prostate Cancer | terminated | Early Phase 1 | 5 | University of California, San FranciscoOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT01684696 | Virtual Intervention for Lung Cancer(VILC) | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT01413503 | A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors | completed | Phase 2 | 50 | University of California, San FranciscoOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT00686127 | Symptom Management After Breast Cancer Surgery | completed | Phase 4 | 21 | University of California, San FranciscoOTHER | 1 | Jun 28, 2018 | clinicaltrials |
| NCT02215161 | Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer | terminated | Phase 2 | 14 | University of California, San FranciscoOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT00617539 | Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases | completed | Phase 2 | 30 | University of California, San FranciscoOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT02966054 | Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial(Smart Pace) | completed | N/A | 42 | University of California, San FranciscoOTHER | 1 | Apr 9, 2018 | clinicaltrials |
| NCT00824538 | Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | terminated | Phase 2 | 13 | University of California, San FranciscoOTHER | 0 | Apr 5, 2018 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials